Friday, June 13
20.00-22.00  Red Hall 1

  Selective aldosterone blockade: evidence of cardioprotective effects in the treatment of hypertension
  Sponsored by Pfizer Inc
   
Chairman:
L. Tavazzi (Pavia, Italy)

> Welcoming remarks
L. Tavazzi (Pavia, Italy)

> Aldosterone: a critical mediator of hypertension and cardiovascular damage
A. Struthers (Dundee, UK)

> Evolution of hypertension treatment strategies: what have we learned?
A. Zanchetti (Milan, Italy)

> Emerging role for selective aldosterone blockade in the treatment of hypertension
L.M. Ruilope (Madrid, Spain)

> EPHESUS: evidence for the cardioprotective effects of selective aldosterone blockade
F. Zannad (Nancy, France)

> Moderated Group Discussion

> Closing Remarks
  For information contact:
Mrs. Roberta Vacca Tornelli
AISC & MGR  - AIM Group
Via A. Ristori, 38 - 00197 Rome (Italy)
Tel. +39-0680968253 - Fax. +39.0680968229
E-Mail: r.vaccatorelli@aisc.it

Back to the Main Programme Index